查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1837513

動物生長促進劑和性能增強劑市場（按產品類型、牲畜類型、配方、應用和分銷管道分類）－2025-2032年全球預測

Animal Growth Promoters & Performance Enhancers Market by Product Type, Livestock Type, Formulation, Application, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，動物生長促進劑和性能增強劑市場規模將達到 329.8 億美元，複合年成長率為 7.04%。

關鍵市場統計數據
基準年2024年 191.3億美元
預計年份：2025年 204.7億美元
預測年份 2032 329.8億美元
複合年成長率 (%) 7.04%

一份策略性產業概覽，揭示了監管壓力、消費者期望和科學創新如何重新定義畜牧生產中的績效改進策略

動物生長和性能增強劑產業處於動物健康、農業生產力和消費者期望的交匯點。不斷成長的蛋白質需求、日益完善的動物福利標準以及抗菌藥物管理舉措正在再形成價值鏈上相關人員的優先事項。因此，傳統上專注於產量和生長的產品現在需要從安全性、殘留、可追溯性和長期牛性能等方面進行評估。市場參與企業如今身處一個多層次的環境中，必須在科學的功效、監管合規性和市場准入等因素之間取得平衡。

在此背景下，創新正朝著生物目標、酶製劑和精準營養方法發展，這些方法旨在增強動物的抵抗力和飼料轉化率，同時應對日益嚴格的抗生素使用審查。同時，商業性需求要求企業證明可衡量的成果，例如提高轉換率和減少治療性介入，以幫助生產者證明採用這些方法的合理性。這意味著該行業正從單一指標的績效聲明轉向綜合價值主張，將功效、安全性和可證明的投資收益相結合，從而惠及生產者和供應鏈合作夥伴。

監管改革、精準配送技術和消費者主導的可追溯性如何融合，重塑產品創新、夥伴關係和市場定位

重大變革正在發生，重塑競爭動態和產品開發重點。首先，許多地區監管環境的日益嚴格，促使人們減少預防性使用抗生素，轉而採用益生元、益生菌和靶向酶等替代方案。這些日益嚴格的監管措施刺激了對非抗生素療法的研究投入，這些療法既能維持生產力，又能降低抗藥性細菌的選擇壓力。其次，數位化精密農業工具能夠更精準地控制生長促進劑的用量和監測，使干涉措施能夠針對特定人群和生命階段進行調整，從而提高療效並最大限度地減少浪費。

同時，供應鏈透明度和麵向消費者的永續性聲明正迫使製造商核實產品的來源和殘留物情況。因此，飼料添加劑製造商、基因相關企業和一體化企業之間的夥伴關係日益普遍，聯合試驗的重點也從單一產品推廣轉向整體績效提升方案。此外，資本配置正轉向生技藥品和微生物解決方案，而傳統化學品則在獸醫監督下進行配方調整或重新定位，以適應特定用途。所有這些轉變共同有利於那些能夠將監管專業知識、強力的功效數據和令人信服的商業性價值證據相結合的靈活創新者。

因應2025年關稅對動物性能增強劑供應鏈的影響，推動區域採購、配方最佳化以及與戰略供應商建立合作關係。

2025年關稅的實施和貿易政策的調整在全球供應鏈中製造了新的摩擦點，並改變了生長促進劑和性能增強劑所用原料的籌資策略和成本結構。活性藥物成分、特種酸和某些微生物菌株的進口關稅提高，增加了依賴全球原料網路的製造商的到岸成本，促使採購團隊盡可能地實現供應商多元化和供應鏈本地化。因此，製造商加快了對替代供應商的資格認證，並投資建設區域儲備，以維持供應的連續性並減少前置作業時間波動。

此外，關稅帶來的成本壓力促使企業重新關注配方效率和價值工程，研發團隊致力於最佳化給藥方案和濃縮液，以減少運輸量和關稅負擔。同時，為因應投入成本波動，生產商尋求合約避險和長期供應商協議。這些因應措施也影響了它們的競爭地位。能夠實現在地化生產或展現強大供應穩定性的公司贏得了大型整合商的信任，而依賴受限進口管道的公司則面臨利潤空間壓縮，並需要加快創新以維繫客戶關係。

透過整合產品化學成分、供應形式、動物生理學和管道動態等訊息，獲得細分市場層面的洞察，從而揭示差異化的市場採納路徑和發展重點。

透過這種細分，我們了解到不同產品類型、牲畜類別、製劑形式、應用領域和分銷管道的需求促進因素和發展重點各不相同。產品類型動態表明，酸化劑、抗生素、BETA-促效劑、酵素、荷爾蒙、益生元和益生菌各自面臨獨特的科學、監管和市場接受度挑戰。例如，酸化劑研究日益關注丁酸、甲酸和丙酸在腸道健康管理方面的應用，而抗生素則繼續受到密切關注，離子載體、大環內酯類、青黴素類和四環黴素是抗菌藥物管理政策的目標。萊克多巴胺和齊帕特羅等BETA-促效劑在某些出口市場仍存在兩極化，促使生產商在療效聲明和市場准入限制之間尋求平衡。酵素的研發重點在於澱粉酶、纖維素酶、植酸酶和蛋白酶的混合物，以釋放飼料中的營養物質並提高轉換率。此外，以雄性激素、雌激素和黃體素為中心的荷爾蒙療法越來越受到動物福利和殘留物考慮的限制，而以微生物為中心的解決方案，包括益生元化學物質如果寡糖和甘露聚醣，以及益生菌菌株如雙叉桿菌、乳酸桿菌和酵母菌，則有助於提高抗病性和生產性能。

考慮到畜牧類型，水產養殖、家禽、反芻動物和豬的生理和管理限制各不相同，這決定了產品的選擇和使用策略。飼料添加劑、注射和水添加劑之間的配方選擇會影響產品的推廣途徑和獸醫的參與程度，而疾病預防、飼料轉換率、生長促進和繁殖性能等方面的應用則需要不同的證據支持和研究設計。分銷管道包括直銷、分銷商和電子商務，每種管道在控制、覆蓋範圍和服務水準方面各有優劣。例如，需要高度個人化支援的企業客戶可能更傾向於面對面的技術支援，而小型農場則擴大利用數位平台來獲取包裝解決方案。

美洲、歐洲、中東和非洲 (EMEA) 以及亞太地區都有其獨特的監管和生產實踐，需要量身定做的產品文件、針對特定地區的測試以及調整後的商業化策略。

區域差異顯著影響美洲、歐洲、中東和非洲以及亞太地區的監管接受度、採用率和戰略重點。在美洲，生產商和監管機構在提高生產力和管理義務之間取得了務實的平衡，通常能夠將新型飼料添加劑的實際應用與系統性監測相結合。相較之下，歐洲、中東和非洲地區的情況則較為複雜：歐洲的監管環境對抗生素的使用和殘留限量要求嚴格，而中東和非洲的多個市場則為推廣經濟高效、耐熱且適應當地生產系統的配方提供了機會。在亞太地區，高密度生產系統、技術的快速普及以及強烈的出口導向推動了對最佳化飼料轉換率和生物安全解決方案的需求，但主導限制也可能使某些化合物的核准變得複雜。

這些地域動態會影響投資和商業化策略。面向全球市場的製造商需要設計靈活的申報資料，以適應不同的核准途徑，並且必須準備好根據不同地區調整標籤和支援方案。此外，區域性研究合作和市場實地試驗對於證明產品在當地條件下的表現至關重要，並能滿足進口商和零售商日益成長的需求，他們要求不同產地的產品殘留和福利證據必須保持一致。

競爭格局分析表明，研發驅動的差異化、策略夥伴關係和供應鏈韌性是動物性能解決方案領域領先地位的關鍵促進因素。

競爭格局由傳統製藥公司、專業飼料添加劑創新企業和新興生技公司共同組成。行業領導者通常具備強大的監管能力、廣泛的測試網路以及與整合商和獸醫的深厚關係，從而能夠高效地將產品推向市場。同時，敏捷的生物技術公司和原料專家正在推動微生物組療法、酵素混合物和靶向酸化劑技術的發展，迫使現有企業進行創新並獲得互補能力。成熟企業與利基市場開發商之間的合作已成為縮短產品驗證時間和拓展產品系列的常見策略。

此外，策略差異化也越來越依賴附加價值服務，例如數位化監測、諮詢專案和綜合營養方案，這些服務能夠展現整體績效的提升。投資於高品質臨床數據、透明殘留檢測和清晰使用說明的公司，將比那些優先考慮合規性的出口導向生產商和零售商更具優勢。最後，鑑於近期貿易中斷和原物料價格波動，供應鏈​​韌性以及在地化生產或採購替代投入品的能力正成為競爭優勢的來源。

製造商和經銷商可採取切實可行的策略性舉措，將證據產生、供應多元化、數位化服務和監管協調相結合，以加速產品應用並降低風險。

產業領導者應優先考慮一系列切實可行的舉措，以確保商業性發展勢頭和監管適應能力。首先，投資進行嚴謹的、經同儕審查的實地研究，以證明產品具有多方面價值，例如提高飼料轉換率、減少治療性介入以及改善殘留物分佈。此類證據將有助於提升一體化企業和出口市場的認可度。其次，加速原料來源多元化，並評估本地生產和清關方案，以降低關稅和運輸風險。這些措施將有助於企業保障淨利率，並確保客戶獲得持續穩定的供應。

第三，開發整合產品功效、數位化監控和諮詢服務的組合方案，以量化結果並增強客戶忠誠度。第四，與微生物組專家、酵素開發商和獸醫網路進行有針對性的合作，在無需承擔全部研發成本的情況下拓展技術廣度。第五，透過繪製重點市場的核准途徑，並在條件允許的情況下投資於統一的安全文件，來最佳化監管策略。結合這些步驟，企業能夠在應對合規和供應鏈複雜性的同時，實現可衡量的績效提升。

我們採用透明的多源研究途徑，結合科學文獻、法規分析、現場試驗回顧和專家訪談，以確保提供可操作的產業洞察。

本分析的調查方法結合了多來源證據，包括同行評審的科學文獻、監管文件、市場試驗數據以及對獸醫、飼料配方師和採購負責人的專家訪談。數據收集重點關注報告了受控性能結果、殘留檢測和跨配方功效比較的研究。調查方法還納入了來自供應鏈和商業負責人的定性意見，以了解籌資策略、利潤壓力和分銷偏好。

分析方法包括對科學發現進行主題綜合、比較政策分析以梳理不同司法管轄區的監管差距，以及情境規劃以評估貿易中斷的營運影響。在條件允許的情況下，我們考慮了經過實地檢驗的參數，以評估統計穩健性和與商業性環境的相關性。在整個過程中，該方法優先考慮透明的假設和可重複的推論，以確保研究結果對技術和商業受眾都具有實際應用價值。

對該行業進行全面、前瞻性的審視，強調需要嚴謹的證據、具有韌性的供應鏈和一體化的服務模式來維持長期的相關性。

總之，動物生長促進劑和性能增強劑產業正處於曲折點，監管預期、供應鏈現狀和科學創新正在重新定義價值創造。能夠用嚴謹的數據證明產品有效性、在貿易緊張局勢下展現供應韌性、並提供符合生產者經濟效益和社會期望的綜合解決方案的企業，才能取得成功。隨著生產者要求提供清晰的性能證據，而買家在採購決策中也越來越重視動物福利和殘留物等因素，產品開發商必須調整其技術藍圖和商業性策略。

展望未來，最具永續的進步很可能來自多學科合作，這些合作將微生物組科學、精準營養和數位監測相結合，並輔以能夠預見不斷變化的核准標準的監管策略。那些現在就採取行動，加強證據收集、實現關鍵投入在地化並建立服務導向提案的公司，將更有利於在複雜的全球價值鏈中獲得長期的相關性和信任。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 畜牧業中擴大採用植物來源飼料添加劑作為非抗生素生長促進劑。
  • 開發針對動物微生物組和生長性能的精準營養配方
  • 對抗生素生長促進劑的更嚴格監管正在推動對益生菌和有機酸等替代促進劑的需求。
  • 增加對先進酵素混合物的投資，以提高飼料轉換率並減少動物生產對環境的影響
  • 基於奈米技術的靶向釋放系統在禽類和豬類性能增強劑方面的進展
  • 在集約化農業環境中，對天然免疫調節劑的需求激增，以促進動物健康和生長。
  • 擴展的數據驅動型飼料最佳化平台，將人工智慧與生長促進劑有效性的即時動物性能分析相結合，從而提升了飼料最佳化平台的功能。
  • 隨著 CRISPR 等基因編輯技術的出現，人們培育出了飼料轉換率更高、肌肉生長潛力更大的牲畜。
  • 人們越來越重視永續性，這推動了環保性能增強劑的研發，這些增強劑可以減少反芻動物的溫室氣體排放。
  • 生物技術公司與飼料生產商合作，將微生物來源的生物活性胜肽商業化，用於促進動物生長。

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：按產品類型分類的動物生長促進劑和性能增強劑市場

  • 酸化劑
    • 丁酸
    • 甲酸
    • 丙酸
  • 抗生素
    • 離子載體
    • 大環內酯類
    • 青黴素
    • 四環黴素
  • BETA-促效劑
    • 萊克多巴胺
    • 齊帕特羅
  • 酵素
    • 澱粉酶
    • 纖維素酶
    • 植酸酶
    • 蛋白酶
  • 荷爾蒙
    • 雄激素
    • 雌激素
    • 黃體素
  • 益生元
    • 寡果醣
    • 甘露聚醣
  • 益生菌
    • 雙歧桿菌
    • 乳酸菌
    • 釀酒酵母

9. 按畜種分類的動物生長促進劑和性能增強劑市場

  • 水產養殖
  • 家禽
  • 反芻動物
  • 豬

第10章：按配方分類的動物生長促進劑和性能增強劑市場

  • 飼料添加劑
  • 注射
  • 水添加物

第11章：按應用分類的動物生長促進劑和性能增強劑市場

  • 疾病預防
  • 飼料效率
  • 促進生長
  • 生育力

第12章：按分銷管道分類的動物生長促進劑和性能增強劑市場

  • 直銷
  • 經銷商
  • 電子商務

第13章：按地區分類的動物生長促進劑和性能增強劑市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 動物生長促進劑和性能增強劑市場（按類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國動物生長促進劑和性能增強劑市場概況

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Elanco Animal Health Incorporated
    • Merck & Co., Inc.
    • Boehringer Ingelheim International GmbH
    • Cargill, Incorporated
    • Archer Daniels Midland Company
    • Koninklijke DSM NV
    • BASF SE
    • Evonik Industries AG
    • Alltech, Inc.
Product Code: MRR-031BF22F9499

The Animal Growth Promoters & Performance Enhancers Market is projected to grow by USD 32.98 billion at a CAGR of 7.04% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 19.13 billion
Estimated Year [2025] USD 20.47 billion
Forecast Year [2032] USD 32.98 billion
CAGR (%) 7.04%

A strategic industry overview revealing how regulatory pressure, consumer expectations, and scientific innovation are redefining performance enhancement strategies in livestock production

The animal growth promoters and performance enhancers sector sits at the intersection of animal health, agricultural productivity, and consumer expectations. Rising protein demand, evolving welfare standards, and antimicrobial stewardship initiatives have reshaped stakeholder priorities across the value chain. Consequently, products that traditionally emphasized yield and growth are increasingly evaluated against safety, residues, traceability, and long-term herd performance. Market participants now navigate a multilayered environment where science-driven efficacy must align with regulatory compliance and market access considerations.

Against this backdrop, innovation is moving toward targeted biologicals, enzyme blends, and precision nutrition approaches that support animal resilience and feed efficiency while responding to heightened scrutiny over antibiotic use. At the same time, commercial imperatives push companies to demonstrate measurable outcomes, such as improved conversion ratios and reduced therapeutic interventions, so that producers can justify adoption. In short, the industry is transitioning from single-metric performance claims toward integrated value propositions that combine efficacy, safety, and demonstrable return on investment for producers and supply-chain partners.

How a convergence of regulatory reform, precision delivery technologies, and consumer-driven traceability is reshaping product innovation, partnerships, and market positioning

Significant transformative shifts are underway that reconstitute competitive dynamics and product development priorities. First, regulatory landscapes have tightened in many jurisdictions, prompting a move away from prophylactic antibiotic use and toward alternatives such as prebiotics, probiotics, and targeted enzymes. This regulatory tightening has driven research investment into non-antibiotic modalities that can sustain productivity while reducing selection pressure for resistant organisms. Second, digital and precision agriculture tools are enabling more targeted delivery and monitoring of growth promoters, so interventions can be tailored to specific cohorts and life stages, improving efficacy and minimizing waste.

Meanwhile, supply chain transparency and consumer-facing sustainability claims are forcing manufacturers to substantiate product provenance and residue profiles. As a result, partnerships between feed additive producers, genetic companies, and integrators are becoming more common, with collaborative pilots focusing on holistic performance programs rather than discrete product placements. In addition, capital allocation has shifted toward biologics and microbiome-focused solutions, while legacy chemistries are being reformulated or repositioned for niche use under veterinary oversight. Collectively, these shifts favor agile innovators that can combine regulatory expertise, strong efficacy data, and compelling commercial evidence of value.

Navigating the 2025 tariff-induced disruption that forced regional sourcing, formulation optimization, and strategic supplier partnerships across the animal performance enhancer supply chain

The imposition of tariffs and trade policy adjustments in 2025 created new friction points for global supply chains, altering sourcing strategies and cost structures for inputs used in growth promoters and performance enhancers. Elevated import duties on active pharmaceutical ingredients, specialty acids, and certain microbial strains increased landed costs for manufacturers that rely on global raw material networks, prompting procurement teams to diversify suppliers and regionalize supply chains where feasible. As a result, manufacturers accelerated qualification of alternate suppliers and invested in regional stockpiles to preserve continuity of supply and mitigate lead-time variability.

Moreover, tariff-driven cost pressures spurred renewed emphasis on formulation efficiency and value engineering, encouraging R&D teams to optimize dosing regimens and concentrate formulations to reduce shipping volumes and duty exposure. In parallel, producers seeking to manage input cost volatility explored contractual hedging and long-term supplier agreements. These responses have implications for competitive positioning: firms able to localize production or demonstrate robust supply continuity gained credibility with large integrators, while those dependent on constrained import channels faced margin compression and accelerated innovation imperatives to maintain customer relationships.

Segment-level intelligence that connects product chemistries, delivery formats, livestock physiologies, and channel dynamics to reveal differentiated adoption pathways and development priorities

Insights from segmentation reveal differentiated demand drivers and development priorities across product types, livestock classes, formulation formats, applications, and distribution channels. Product-type dynamics show that acidifiers, antibiotics, beta agonists, enzymes, hormones, prebiotics, and probiotics each face unique scientific, regulatory, and market acceptance challenges; for example, acidifier research increasingly focuses on butyric, formic, and propionic acids for gut health management, while antibiotics continue to be scrutinized with ionophores, macrolides, penicillins, and tetracyclines subject to stewardship policies. Beta agonists such as ractopamine and zilpaterol remain polarizing in certain export markets, prompting manufacturers to balance efficacy claims with access constraints. Enzyme development emphasizes amylase, cellulase, phytase, and protease blends that unlock feed nutrients and improve conversion, and hormonal approaches centered on androgens, estrogens, and progestins are increasingly governed by welfare and residue considerations. Microbiome-focused solutions highlight prebiotic chemistries like fructooligosaccharides and mannan oligosaccharides and probiotic strains such as Bifidobacterium, Lactobacillus, and Saccharomyces that support disease resistance and performance.

When considering livestock type, aquaculture, poultry, ruminants, and swine present distinct physiological and management constraints that determine product selection and dosing strategies, with aquaculture's water-based delivery and poultry's rapid turnover calling for different formulation priorities than ruminant or swine systems. Formulation choices between feed additives, injectables, and water additives influence adoption pathways and veterinarian involvement, while applications across disease prevention, feed efficiency, growth promotion, and reproductive performance require tailored evidence packages and trial designs. Distribution channels comprising direct sales, distributors, and e-commerce each offer trade-offs between control, reach, and service level; for example, high-touch institutional customers may prefer direct relationships for technical support, whereas smaller farms increasingly leverage digital platforms to access packaged solutions.

Region-specific regulatory and production realities that require tailored product dossiers, localized trials, and adaptive commercialization strategies across the Americas, EMEA, and Asia-Pacific

Regional nuances materially influence regulatory tolerance, adoption rates, and strategic priorities across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, producers and regulators display a pragmatic balance between productivity gains and stewardship obligations, often enabling pragmatic rollouts of novel feed additives alongside structured surveillance. Conversely, the Europe, Middle East & Africa region presents a heterogeneous landscape where European regulatory regimes are stringent on antibiotic use and residue limits, while several Middle Eastern and African markets present opportunities for scaling cost-effective, heat-resistant formulations adapted to local production systems. In Asia-Pacific, high-density production systems, rapid technology adoption, and strong export orientation drive demand for solutions that optimize feed conversion and biosecurity, although trade-driven constraints can complicate certain compound approvals.

These geographic dynamics influence investment and commercialization strategies. Manufacturers targeting global accounts must design adaptable dossiers to meet divergent approval pathways, and they must be prepared to differentiate labeling and support packages by region. In addition, regional research partnerships and in-market field trials are essential to demonstrate performance under local conditions and to satisfy importers and retailers who increasingly demand consistent residue and welfare evidence across sourcing geographies.

Competitive landscape analysis emphasizing R&D-backed differentiation, strategic partnerships, and supply chain resilience as decisive factors for leadership in animal performance solutions

Competitive dynamics are defined by a mix of legacy pharmaceutical firms, specialized feed additive innovators, and emerging biotech entrants. Leading players often combine robust regulatory affairs capabilities with expansive trial networks and deep relationships with integrators and veterinarians, which enables efficient pathway-to-market execution. At the same time, nimble biotech companies and ingredient specialists are advancing microbiome therapeutics, enzyme blends, and targeted acidifier technologies, creating pressure on incumbents to innovate or acquire complementary capabilities. Collaboration between large firms and niche developers has become a common strategy to accelerate time-to-evidence and broaden product portfolios.

In addition, strategic differentiation increasingly hinges on value-added services such as digital monitoring, advisory programs, and bundled nutrition plans that demonstrate holistic performance improvements. Firms that invest in high-quality clinical data, transparent residue studies, and clear use instructions gain advantage with export-oriented producers and retailers focused on compliance. Finally, supply chain resilience and the ability to localize manufacturing or source alternate inputs are emerging as competitive levers, given recent trade disruptions and raw material volatility.

Practical strategic moves for manufacturers and distributors that combine evidence generation, supply diversification, digital services, and regulatory alignment to accelerate adoption and reduce risk

Industry leaders should prioritize a set of actionable initiatives to secure commercial momentum and regulatory resilience. First, invest in rigorous, peer-reviewed field studies that demonstrate multi-dimensional value: improved feed efficiency, reduced therapeutic interventions, and robust residue profiles. Such evidence will expedite acceptance among integrators and export markets. Second, accelerate diversification of raw material sources and evaluate regional manufacturing or tolling options to mitigate tariff and transport risks. By doing so, companies can protect margins and assure customers of supply continuity.

Third, develop integrated offerings that combine product efficacy with digital monitoring and advisory services to quantify outcomes and reinforce customer loyalty. Fourth, pursue targeted collaborations with microbiome specialists, enzyme developers, and veterinary networks to expand technical breadth without bearing the full cost of discovery. Fifth, refine regulatory strategies by mapping approval pathways across priority markets and investing in harmonized safety dossiers where feasible. Taken together, these steps will position companies to deliver measurable performance improvements while managing compliance and supply-chain complexity.

A transparent, multi-source research approach combining scientific literature, regulatory analysis, field trial review, and expert practitioner interviews to ensure actionable industry insights

The research methodology underpinning this analysis combines a multi-source evidence approach, triangulating peer-reviewed scientific literature, regulatory filings, in-market field trial data, and expert interviews with veterinarians, feed formulators, and procurement leaders. Data collection emphasized studies that report controlled performance outcomes, residue testing, and comparative efficacy across formulations. In addition, the methodology incorporated qualitative inputs from supply chain and commercial leaders to understand sourcing strategies, margin pressures, and distribution preferences.

Analytical techniques included thematic synthesis of scientific findings, comparative policy analysis to map regulatory divergence across jurisdictions, and scenario planning to assess the operational impact of trade disruptions. Where available, field trial parameters were reviewed to assess statistical robustness and relevance to commercial conditions. Throughout, the approach prioritized transparent assumptions and reproducible reasoning to ensure findings are actionable for both technical and commercial audiences.

A forward-looking synthesis highlighting the necessity of rigorous evidence, resilient supply chains, and integrated service models to sustain long-term industry relevance

In conclusion, the animal growth promoters and performance enhancers sector is at an inflection point where regulatory expectations, supply-chain realities, and scientific innovation converge to redefine value creation. Success will accrue to organizations that can substantiate efficacy with rigorous data, demonstrate supply resilience in the face of trade friction, and deliver integrated solutions that align with producer economics and societal expectations. As producers demand clearer evidence of performance and as buyers increasingly factor welfare and residue considerations into sourcing decisions, product developers must adapt both their technical roadmaps and commercial narratives.

Looking ahead, the most sustainable advances will emerge from cross-disciplinary collaborations that integrate microbiome science, precision nutrition, and digital monitoring, supported by regulatory strategies that anticipate shifting approval criteria. Firms that act now to shore up evidence, localize critical inputs, and build service-oriented propositions will be best positioned to capture long-term relevance and trust across complex global value chains.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of plant-derived phytogenic feed additives as non-antibiotic growth promoters in livestock
  • 5.2. Development of precision nutrition formulations tailored to animal microbiome and growth performance
  • 5.3. Growing regulatory restrictions on antibiotic growth promoters boosting demand for alternative enhancers like probiotics and organic acids
  • 5.4. Increased investment in advanced enzyme blends to improve feed conversion and reduce environmental impact from animal production
  • 5.5. Advancement in nanotechnology-based delivery systems for targeted release of performance enhancers in poultry and swine
  • 5.6. Surge in demand for natural immunomodulators to enhance animal health and growth under intensive farming conditions
  • 5.7. Expansion of data-driven feed optimization platforms integrating real-time animal performance analytics and AI for growth promoter efficacy
  • 5.8. Emergence of gene editing technologies like CRISPR to develop livestock with superior feed efficiency and muscle growth potential
  • 5.9. Rising focus on sustainability leading to development of eco-friendly performance enhancers that reduce greenhouse gas emissions from ruminants
  • 5.10. Collaboration between biotech companies and feed manufacturers to commercialize microbial-derived bioactive peptides for growth promotion

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Animal Growth Promoters & Performance Enhancers Market, by Product Type

  • 8.1. Acidifiers
    • 8.1.1. Butyric Acid
    • 8.1.2. Formic Acid
    • 8.1.3. Propionic Acid
  • 8.2. Antibiotics
    • 8.2.1. Ionophores
    • 8.2.2. Macrolides
    • 8.2.3. Penicillins
    • 8.2.4. Tetracyclines
  • 8.3. Beta Agonists
    • 8.3.1. Ractopamine
    • 8.3.2. Zilpaterol
  • 8.4. Enzymes
    • 8.4.1. Amylase
    • 8.4.2. Cellulase
    • 8.4.3. Phytase
    • 8.4.4. Protease
  • 8.5. Hormones
    • 8.5.1. Androgens
    • 8.5.2. Estrogens
    • 8.5.3. Progestins
  • 8.6. Prebiotics
    • 8.6.1. Fructooligosaccharides
    • 8.6.2. Mannan Oligosaccharides
  • 8.7. Probiotics
    • 8.7.1. Bifidobacterium
    • 8.7.2. Lactobacillus
    • 8.7.3. Saccharomyces

9. Animal Growth Promoters & Performance Enhancers Market, by Livestock Type

  • 9.1. Aquaculture
  • 9.2. Poultry
  • 9.3. Ruminants
  • 9.4. Swine

10. Animal Growth Promoters & Performance Enhancers Market, by Formulation

  • 10.1. Feed Additives
  • 10.2. Injectable Formulations
  • 10.3. Water Additives

11. Animal Growth Promoters & Performance Enhancers Market, by Application

  • 11.1. Disease Prevention
  • 11.2. Feed Efficiency
  • 11.3. Growth Promotion
  • 11.4. Reproductive Performance

12. Animal Growth Promoters & Performance Enhancers Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributors
  • 12.3. E Commerce

13. Animal Growth Promoters & Performance Enhancers Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Animal Growth Promoters & Performance Enhancers Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Animal Growth Promoters & Performance Enhancers Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Elanco Animal Health Incorporated
    • 16.3.2. Merck & Co., Inc.
    • 16.3.3. Boehringer Ingelheim International GmbH
    • 16.3.4. Cargill, Incorporated
    • 16.3.5. Archer Daniels Midland Company
    • 16.3.6. Koninklijke DSM N.V.
    • 16.3.7. BASF SE
    • 16.3.8. Evonik Industries AG
    • 16.3.9. Alltech, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY LIVESTOCK TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY LIVESTOCK TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FORMULATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ACIDIFIERS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ACIDIFIERS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ACIDIFIERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ACIDIFIERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ACIDIFIERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ACIDIFIERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ACIDIFIERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ACIDIFIERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BUTYRIC ACID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BUTYRIC ACID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BUTYRIC ACID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BUTYRIC ACID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BUTYRIC ACID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BUTYRIC ACID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FORMIC ACID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FORMIC ACID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FORMIC ACID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FORMIC ACID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FORMIC ACID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FORMIC ACID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROPIONIC ACID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROPIONIC ACID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROPIONIC ACID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROPIONIC ACID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROPIONIC ACID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROPIONIC ACID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ANTIBIOTICS, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ANTIBIOTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ANTIBIOTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ANTIBIOTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ANTIBIOTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY IONOPHORES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY IONOPHORES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY IONOPHORES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY IONOPHORES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY IONOPHORES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY IONOPHORES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY MACROLIDES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY MACROLIDES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY MACROLIDES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY MACROLIDES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY MACROLIDES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY MACROLIDES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PENICILLINS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PENICILLINS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PENICILLINS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PENICILLINS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PENICILLINS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PENICILLINS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY TETRACYCLINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY TETRACYCLINES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY TETRACYCLINES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY TETRACYCLINES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY TETRACYCLINES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY TETRACYCLINES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BETA AGONISTS, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BETA AGONISTS, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BETA AGONISTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BETA AGONISTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BETA AGONISTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BETA AGONISTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BETA AGONISTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BETA AGONISTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY RACTOPAMINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY RACTOPAMINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY RACTOPAMINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY RACTOPAMINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY RACTOPAMINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY RACTOPAMINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ZILPATEROL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ZILPATEROL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ZILPATEROL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ZILPATEROL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ZILPATEROL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ZILPATEROL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ENZYMES, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ENZYMES, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ENZYMES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ENZYMES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ENZYMES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ENZYMES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ENZYMES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ENZYMES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY AMYLASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY AMYLASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY AMYLASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY AMYLASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY AMYLASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY AMYLASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY CELLULASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY CELLULASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY CELLULASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY CELLULASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY CELLULASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY CELLULASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PHYTASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PHYTASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PHYTASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PHYTASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PHYTASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PHYTASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROTEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROTEASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROTEASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROTEASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROTEASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROTEASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY HORMONES, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY HORMONES, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY HORMONES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY HORMONES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY HORMONES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY HORMONES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY HORMONES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY HORMONES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ANDROGENS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ANDROGENS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ANDROGENS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ANDROGENS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ANDROGENS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ANDROGENS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ESTROGENS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ESTROGENS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ESTROGENS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ESTROGENS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ESTROGENS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ESTROGENS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROGESTINS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROGESTINS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROGESTINS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROGESTINS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROGESTINS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROGESTINS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PREBIOTICS, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PREBIOTICS, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PREBIOTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PREBIOTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PREBIOTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PREBIOTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PREBIOTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PREBIOTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FRUCTOOLIGOSACCHARIDES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FRUCTOOLIGOSACCHARIDES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FRUCTOOLIGOSACCHARIDES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FRUCTOOLIGOSACCHARIDES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FRUCTOOLIGOSACCHARIDES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FRUCTOOLIGOSACCHARIDES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY MANNAN OLIGOSACCHARIDES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY MANNAN OLIGOSACCHARIDES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY MANNAN OLIGOSACCHARIDES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY MANNAN OLIGOSACCHARIDES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY MANNAN OLIGOSACCHARIDES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY MANNAN OLIGOSACCHARIDES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROBIOTICS, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROBIOTICS, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROBIOTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROBIOTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROBIOTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROBIOTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROBIOTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BIFIDOBACTERIUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BIFIDOBACTERIUM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BIFIDOBACTERIUM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BIFIDOBACTERIUM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BIFIDOBACTERIUM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BIFIDOBACTERIUM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY LACTOBACILLUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY LACTOBACILLUS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY LACTOBACILLUS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY LACTOBACILLUS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY LACTOBACILLUS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY LACTOBACILLUS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY SACCHAROMYCES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY SACCHAROMYCES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY SACCHAROMYCES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY SACCHAROMYCES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY SACCHAROMYCES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY SACCHAROMYCES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY LIVESTOCK TYPE, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY LIVESTOCK TYPE, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY AQUACULTURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY AQUACULTURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY AQUACULTURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY AQUACULTURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY AQUACULTURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY AQUACULTURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY POULTRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY POULTRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY POULTRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY POULTRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY POULTRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY POULTRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY RUMINANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY RUMINANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY RUMINANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY RUMINANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY RUMINANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY RUMINANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY SWINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY SWINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY SWINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY SWINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY SWINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY SWINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FEED ADDITIVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FEED ADDITIVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FEED ADDITIVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FEED ADDITIVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FEED ADDITIVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FEED ADDITIVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY INJECTABLE FORMULATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY INJECTABLE FORMULATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY INJECTABLE FORMULATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY INJECTABLE FORMULATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY INJECTABLE FORMULATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY INJECTABLE FORMULATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY WATER ADDITIVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY WATER ADDITIVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY WATER ADDITIVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY WATER ADDITIVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY WATER ADDITIVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY WATER ADDITIVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY DISEASE PREVENTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY DISEASE PREVENTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY DISEASE PREVENTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY DISEASE PREVENTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY DISEASE PREVENTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY DISEASE PREVENTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FEED EFFICIENCY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FEED EFFICIENCY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FEED EFFICIENCY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FEED EFFICIENCY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FEED EFFICIENCY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FEED EFFICIENCY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY GROWTH PROMOTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY GROWTH PROMOTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY GROWTH PROMOTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY GROWTH PROMOTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY GROWTH PROMOTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY GROWTH PROMOTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY RE